ASHUMGulf news and Dubai stocks, live

Detailed analysis of the accumulated losses WATANIA

Watania International Holding PJSC 2 pages

Document2 pages, text from the fileOpen DFM’s file

Page 1

Watania International HoldingDetailed analysis of accumulated losses

This form has been prepared in accordance with the disclosure requirements included in the SCA Board of Directors’ Decision No. (32/R.M.) of 2019 concerning procedures for companies whose shares are listed on the market, and whose accumulated losses amount to (20%) or more of their paid-up capital. Listed Companies are required to comply with the provisions of the decision as soon as their accumulated losses reach (20%) or more of their paid-up capital.

26 March 2024 Date:Watania International Holding PJSC Name of the Listed Company:Full year 2023Define the period of thefinancial statements:AED 45.9MValue of the Accumulatedlosses:17.67%Accumulated losses to paid-upcapital ratio (%):

The company reported an exceptional loss of AED53million in FY22 due to one-off merger costs, the increased hospital utilization post covid and market driven pricing pressures during the pandemic.

The main reasons foraccumulated losses and theperiod in which these lossesbegan. (Determine the periodin which these losses began toappear in the company'sfinancial statements):

2023 was a year of transition whereby we executed a successful turnaround strategy to recover from the significant losses in 2022 and to achieve a profit of AED13.3M at the close of the financial year.

This was mainly driven by concerted efforts to implement the integration process following the merger completed in July 2022, and to achieve a performance turnaround by leveraging the unlocked revenue growth opportunities from our consolidated operations and resetting the Company’s business operations to benefit from more normalized market conditions in the post Covid period.

Summary of the steps andinitiatives undertaken by thecompany to address theaccumulated losses:

Page 2

The Measures that will be taken to deal with the accumulated losses.

ActionsThe timeframe forimplementing theactionWhat has been implemented ofthe action and the percentageof implementationReasons fornotimplementingor delayingAnymodificationsor changesmadeRealignmentof productpricing.

FY23 We have realigned our product pricing for our major segments in Medical and Motor. The

Company achieved a steady

result at the end of the financial year 2023 due to significant

improvements in the results of the Medical and Motor lines of business.

Not Applicable Not ApplicableRealignmentofunderwriting.FY23 We have realigned our

underwriting parameters for our major segments, specifically the Medical and Motor portfolios. The Company achieved a steady

result at the end of the financial year 2023 due to significant

improvements in the results of Medical and Motor line of

business.Not Applicable Not ApplicableFocus onimprovinginvestmentyield.FY23 We have de-risked our

investment portfolio and moved the majority of our investments into fixed yield generating assets.

We have seen an improvementof close to 400-bps in our

investment yield for FY23. 100% achieved

Not Applicable Not ApplicableRealization ofcost synergiesof merger.

FY23 We have started realizing the cost synergies of the merger

where we expect to save around AED 20mn on an annualized

basis. Cost synergies achieved for FY23 are in-line with the target.

Not Applicable Not Applicable

Gautam Datta The Name of the Authorized Signatory Chief Executive Officer Designation 26 March 2024 Signature and Date Company’s Seal